Our research focuses on cancer nanotechnology for precision medicine to tackle crucial medical problems involved in the development of novel and highly effective diagnostic and therapy platforms for cancer. Cancer has become the chief innovator of ground-breaking platforms that can be used for precision medicine. Determining the response profile of a tumor, detecting key players in tumor progression, and trying to disable those drivers is the modus operandi of our research. Cancer nanotechnology is a burgeoning field. It is now crucial to empower of nanomedicine to differentially combat cancer using smart and targeted platforms that mediate highly selective therapies within the tumor microenvironment. The lack of standardized means to treat and profile the tumor microenvironment calls for a paradigm shift in the way we view and treat cancer. In this paradigm, Joao Conde’s research and his seminar focus will be on tackling real biomedical problems and developing smart materials to beat cancer.